Association Between Single-nucleotide Polymorphisms in MiRNA and Breast Cancer Risk: an Updated Review

Overview

Journal Biol Res

Specialty Biology

Date 2021 Aug 29

PMID 34454612

Citations 10

Authors

Trinidad Arancibia

Sebastian Morales-Pison

Edio Maldonado

Lilian Jara

Affiliations

Soon will be listed here.

Abstract

Breast cancer (BC), a heterogeneous, aggressive illness with high mortality, is essentially a genomic disease. While the high-penetrance genes BRCA1 and BRCA2 play important roles in tumorigenesis, moderate- and low-penetrance genes are also involved. Single-nucleotide polymorphisms (SNPs) in microRNA (miRNA) genes have recently been identified as BC risk factors. miRNA genes are currently classified as low-penetrance. SNPs are the most common variations in the human genome. While the role of miRNA SNPs in BC susceptibility has been studied extensively, results have been inconsistent. This review analyzes the results of association studies between miRNA SNPs and BC risk from countries around the world. We conclude that: (a) By continent, the largest proportion of studies to date were conducted in Asia (65.0 %) and the smallest proportion in Africa (1.8 %); (b) Association studies have been completed for 67 different SNPs; (c) 146a, 196a2, 499, 27a, and 423 are the most-studied miRNAs; (d) The SNPs rs2910164 (miRNA-146a), rs11614913 (miRNA-196a2), rs3746444 (miRNA-499) and rs6505162 (miRNA-423) were the most widely associated with increased BC risk; (e) The majority of studies had small samples, which may affect the precision and power of the results; and (f) The effect of an SNP on BC risk depends on the ethnicity of the population. This review also discusses potential explanations for controversial findings.

Citing Articles

The impact of ADAMTS14 genetic polymorphisms and its function on susceptibility to and prognosis of gastric cancer in a Chinese Han population.

Li P, Dong J, Li Y, Yan J, Wang J, Cao S Gastric Cancer. 2025; .

PMID: 39992602 DOI: 10.1007/s10120-025-01598-7.

rs11614913 C Allele is Associated with Increased Wilms Tumor Susceptibility in Chinese Children.

Luo M, Wang Y, Yin H, Zhou C, Lu H, Zhou H J Cancer. 2025; 16(2):479-485.

PMID: 39744493 PMC: 11685685. DOI: 10.7150/jca.102801.

miRNA genetic variations associated with the predisposition of oral squamous cell carcinoma in central Indian population.

Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Nema R Noncoding RNA Res. 2024; 9(4):1333-1341.

PMID: 39131689 PMC: 11315085. DOI: 10.1016/j.ncrna.2024.07.002.

Amplification-Free Strategy for miRNA Quantification in Human Serum Using Single Particle ICP-MS and Gold Nanoparticles as Labels.

Gonzalez Morales S, Lopez-Portugues C, Fernandez-Sanjurjo M, Iglesias-Gutierrez E, Montes Bayon M, Corte-Rodriguez M Anal Chem. 2024; .

PMID: 39028890 PMC: 11295127. DOI: 10.1021/acs.analchem.4c01904.

Causal effects and metabolites mediators between immune cell and risk of breast cancer: a Mendelian randomization study.

Ming R, Wu H, Liu H, Zhan F, Qiu X, Ji M Front Genet. 2024; 15:1380249.

PMID: 38826800 PMC: 11140059. DOI: 10.3389/fgene.2024.1380249.

References

Meshkat M, Mesrian Tanha H, Naeini M, Ghaedi K, Sanati M, Meshkat M . Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival. Cancer Biomark. 2016; 17(2):213-22. DOI: 10.3233/CBM-160633. View

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

Ciriello G, Sinha R, Hoadley K, Jacobsen A, Reva B, Perou C . The molecular diversity of Luminal A breast tumors. Breast Cancer Res Treat. 2013; 141(3):409-20. PMC: 3824397. DOI: 10.1007/s10549-013-2699-3. View

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S . The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102(52):19075-80. PMC: 1323209. DOI: 10.1073/pnas.0509603102. View

Esteban Cardenosa E, de Juan Jimenez I, Palanca Suela S, Gonzalez I, Segura Huerta A, Santaballa Beltran A . Low penetrance alleles as risk modifiers in familial and sporadic breast cancer. Fam Cancer. 2012; 11(4):629-36. DOI: 10.1007/s10689-012-9563-1. View

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

Zhang N, Huo Q, Wang X, Chen X, Long L, Jiang L . A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population. Gene. 2013; 529(1):125-30. DOI: 10.1016/j.gene.2013.07.041. View

Kumar Bodal V, Sangwan S, Bal M, Kaur M, Sharma S, Kaur B . Association between Microrna 146a and Microrna 196a2 Genes Polymorphism and Breast Cancer Risk in North Indian Women. Asian Pac J Cancer Prev. 2017; 18(9):2345-2348. PMC: 5720634. DOI: 10.22034/APJCP.2017.18.9.2345. View

Alshatwi A, Shafi G, Hasan T, Syed N, Al-Hazzani A, Alsaif M . Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One. 2012; 7(2):e30049. PMC: 3282723. DOI: 10.1371/journal.pone.0030049. View

10.

Qi P, Wang L, Zhou B, Yao W, Xu S, Zhou Y . Associations of miRNA polymorphisms and expression levels with breast cancer risk in the Chinese population. Genet Mol Res. 2015; 14(2):6289-96. DOI: 10.4238/2015.June.11.2. View

11.

Siasi E, Solimani M . Associations of Single Nucleotide Polymorphism in miR-146a Gene with Susceptibility to Breast Cancer in the Iranian Female. Asian Pac J Cancer Prev. 2020; 21(6):1585-1593. PMC: 7568866. DOI: 10.31557/APJCP.2020.21.6.1585. View

12.

Ciafre S, Galardi S, Mangiola A, Ferracin M, Liu C, Sabatino G . Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005; 334(4):1351-8. DOI: 10.1016/j.bbrc.2005.07.030. View

13.

Chen Q, Wang Q, Zhang B . Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis. Tumour Biol. 2013; 35(1):529-43. DOI: 10.1007/s13277-013-1074-7. View

14.

Danesh H, Hashemi M, Bizhani F, Hashemi S, Bahari G . Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population. Gene. 2018; 647:73-78. DOI: 10.1016/j.gene.2018.01.025. View

15.

Penrose L, MacKENZIE H, KARN M . A genetical study of human mammary cancer. Ann Eugen. 1948; 14 Pt(3):234-66. DOI: 10.1111/j.1469-1809.1947.tb02399.x. View

16.

Iorio M, Casalini P, Piovan C, Braccioli L, Tagliabue E . Breast cancer and microRNAs: therapeutic impact. Breast. 2011; 20 Suppl 3:S63-70. DOI: 10.1016/S0960-9776(11)70297-1. View

17.

Sanaei S, Hashemi M, Rezaei M, Hashemi S, Bahari G, Ghavami S . Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk. Biomed Rep. 2016; 5(1):125-129. PMC: 4906800. DOI: 10.3892/br.2016.690. View

18.

Le M, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V . MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 2009; 23(7):862-76. PMC: 2666337. DOI: 10.1101/gad.1767609. View

19.

ODay E, Lal A . MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 2010; 12(2):201. PMC: 2879559. DOI: 10.1186/bcr2484. View

20.

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View